Status:
RECRUITING
CT Prediction for Transcatheter Tricuspid Interventions
Lead Sponsor:
Heart and Diabetes Center North-Rhine Westfalia
Collaborating Sponsors:
Ludwig-Maximilians - University of Munich
University Hospital Schleswig-Holstein
Conditions:
Tricuspid Regurgitation
Computed Tomography
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to enhance the predictability of therapeutic success in transcatheter tricuspid valve intervention (TTVI) for patients with severe tricuspid regurgitation (TR). This will be a...
Eligibility Criteria
Inclusion
- the patient underwent full cycle cardiac computed tomography for analysis of valvular heart disease
- a transcatheter tricuspid valve intervention is performed
- the patient is 18 years or older
Exclusion
- none
Key Trial Info
Start Date :
July 19 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06951126
Start Date
July 19 2023
End Date
June 1 2030
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herz- und Diabeteszentrum
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545